Dechert LLP advised biopharmaceutical company Prexton Therapeutics B.V. (Prexton) and its selling shareholders, including M Ventures, in the deal. H. Lundbeck A/S and Prexton Therapeutics BV…
Lundbeck’s €905 Million Acquisition of Prexton Therapeutics
